Results
|
|
121.
|
Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma. [electronic resource] by
- Cheung, Belamy B
- Tan, Owen
- Koach, Jessica
- Liu, Bing
- Shum, Michael S Y
- Carter, Daniel R
- Sutton, Selina
- Po'uha, Sela T
- Chesler, Louis
- Haber, Michelle
- Norris, Murray D
- Kavallaris, Maria
- Liu, Tao
- O'Neill, Geraldine M
- Marshall, Glenn M
Producer: 20160603
In:
Molecular oncology vol. 9
Availability: No items available.
|
|
|
122.
|
|
|
|
123.
|
|
|
|
124.
|
|
|
|
125.
|
|
|
|
126.
|
|
|
|
127.
|
|
|
|
128.
|
|
|
|
129.
|
|
|
|
130.
|
|
|
|
131.
|
|
|
|
132.
|
|
|
|
133.
|
|
|
|
134.
|
|
|
|
135.
|
|
|
|
136.
|
|
|
|
137.
|
Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma. [electronic resource] by
- Watanabe, Takashi
- Kato, Harumi
- Kobayashi, Yukio
- Yamasaki, Satoshi
- Morita-Hoshi, Yuriko
- Yokoyama, Hiroki
- Morishima, Yasuo
- Ricker, Justin L
- Otsuki, Tetsuya
- Miyagi-Maesima, Akiko
- Matsuno, Yoshihiro
- Tobinai, Kensei
Producer: 20100330
In:
Cancer science vol. 101
Availability: No items available.
|
|
|
138.
|
|
|
|
139.
|
|
|
|
140.
|
|